Analgesia and sedation during mechanical ventilation in paediatrics

  • M. L. Massone
  • L. Manfredini
  • G. Ottonello
Conference paper


In paediatric intensive care units (PICU) critically ill children experience various stimuli perceived as disturbing, frightening and dangerous. Maintaining a good level of comfort while preserving safety is a main part of the care in mechanically ventilated patients and the use of sedatives and analgesics is recommended in these circumstances [1, 2].


Paediatric Intensive Care Unit Neuromuscular Blockade Bispectral Index Refractory Status Epilepticus Procedural Sedation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    ACCM of SCCM (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30:119–141CrossRefGoogle Scholar
  2. 2.
    Playfor SD, Thomas DA, Choonara I et al (2000) Quality of sedation during mechanical ventilation. Paed Anaesth 10(2):195–199CrossRefGoogle Scholar
  3. 3.
    Crean P (2004) Sedation and neuromuscular blockade in paediatric intensive care; practice in the United Kingdom and North America. Paed Anaesth 14(6):439–442CrossRefGoogle Scholar
  4. 4.
    Ambuel B, Hamlett KW, Marx CM et al (1992) Assessing distress in pediatric intensive care environments-The COMFORT Scale. J Pediatr Psychol 17:95–109PubMedCrossRefGoogle Scholar
  5. 5.
    Marx CM, Smith PG, Lowrie LH (1994) Optimal sedation of mechanically ventilated pediatric critical care patients. Crit Care Med 22:163–170PubMedGoogle Scholar
  6. 6.
    van Dijk M, de Boer JB, Koot HM et al (2000) The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old infants. Pain 84(2-3):367–377PubMedCrossRefGoogle Scholar
  7. 7.
    Ramsay MA, Savege TM, Simpson BR et al (1974) Controlled sedation with alphaxolone-alphadolone. Br Med J 2:656–659PubMedCrossRefGoogle Scholar
  8. 8.
    Parkinson L, Hughes J, Gill A et al (1997) A randomized controlled trial of sedation in the critically ill. Paed Anaesth 7:405–410CrossRefGoogle Scholar
  9. 9.
    Ratcliffe JM (1994) Sedation in the intensive care unit. Curr Paediatr 4:106–109CrossRefGoogle Scholar
  10. 10.
    Berkenbosch JW, Fitcher CR, Tobias JD (2002) The correlation of the Bispectral Index Monitor with clinical sedation scores during mechanical ventilation in the pediatric intensive care unit. Anesth Analg 94:506–511PubMedCrossRefGoogle Scholar
  11. 11.
    Aneja R, Heard AMB, Fletcher JE et al (2003) Sedation monitoring of children by the bispectral index in the pediatric intensive care unit. Pediatr Crit Care Med 4:60–64PubMedCrossRefGoogle Scholar
  12. 12.
    Tobias JD, Grindstaff R (2005) Bispectral Index Monitoring during the administration of neuromuscular blocking agents in the pediatric intensive care unit patient. J Intensive Care Med 20:233–237PubMedCrossRefGoogle Scholar
  13. 13.
    Powers KS, Nazarian EB, Tapyrik SA et al (2005) Bispectral Index as a guide for titration of Propofol during procedural sedation among children. Pediatrics 115:1666–1674PubMedCrossRefGoogle Scholar
  14. 14.
    Frenzel D, Griem CA, Sommer C et al (2002) Is the bispectral index appropriate for monitoring the sedation level of mechanically ventilated surgical ICU patients? Intensive Care Med 28(2):178–183PubMedCrossRefGoogle Scholar
  15. 15.
    Playfor SD, Thomas DA, Choonara I (2003) Sedation and neuromuscular blockade in paediatric intensive care: a review of current practice in the UK. Paed Anaesth 13(2):147–151CrossRefGoogle Scholar
  16. 16.
    Twite MD, Rashid A, Friesen RH (2004) Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med 5(6):521–532PubMedCrossRefGoogle Scholar
  17. 17.
    Tobias JD (2005) Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 34(8):636–645PubMedGoogle Scholar
  18. 18.
    Nahara MC, McMorrow J, Jones PR et al (2000) Pharmacokinetics of midazolam in critically ill pediatric patients. Eur J Drug Metab Pharmacokinet 25(3–4):219–221PubMedGoogle Scholar
  19. 19.
    de Wildt SN, de Hoog M, Vinks AA et al (2003) Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients. Crit Care Med 31(7):1952–1958PubMedCrossRefGoogle Scholar
  20. 20.
    Blumer JL (1998) Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 35(1):37–47PubMedCrossRefGoogle Scholar
  21. 21.
    Ng E, Taddio A, Ohlsson A (2003) Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database of Systematic Reviews (1):CD002052Google Scholar
  22. 22.
    Chicella M, Jansen P, Parthiban A et al (2002) Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med 30(12):2752–2756PubMedCrossRefGoogle Scholar
  23. 23.
    Appleton R, Martland T, Phillips B (2002) Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev (4):CD001905Google Scholar
  24. 24.
    Dominguez KD, Crowley MR, Coleman DM et al (2006) Withdrawal from lorazepam in critically ill children (2006). Ann Pharmacother 40(6):1035–1039PubMedCrossRefGoogle Scholar
  25. 25.
    Parke TJ, Stevens JE, Rice AS et al (1992) Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 305(6854):613–616PubMedGoogle Scholar
  26. 26.
    Bray RJ (1998) Propofol infusion syndrome in children. Paed Anaesth 8(6):491–499CrossRefGoogle Scholar
  27. 27.
    Wolf A, Weir P, Segar P et al (2001) Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357(9256):606–607PubMedCrossRefGoogle Scholar
  28. 28.
    Withington DE, Decell MK, Al Ayed T (2004) A case of propofol toxicity: further evidence for a causal mechanism. Paed Anaesth 14(6):505–508CrossRefGoogle Scholar
  29. 29.
    Cornfield DN, Tegtmeyer K, Nelson MD et al (2002) Continuous propofol infusion in 142 critically ill children. Pediatrics 110(6):1177–1181PubMedCrossRefGoogle Scholar
  30. 30.
    Festa M, Bowra J, Schell D (2002) Use of propofol infusion in Australian and New Zealand paediatric intensive care units. Anaesth Intensive Care 30(6):786–793PubMedGoogle Scholar
  31. 31.
    Playfor SD, Venkatesh K (2004) Current patterns of propofol use in PICUin the United Kingdom and North America. Paed Anaesth 14(6):501–504CrossRefGoogle Scholar
  32. 32.
    Felmet K, Nguyen T, Clark RS et al (2003) The FDA warning against prolonged sedation with propofol in children remains warranted (letter). Pediatrics 112:1002–1003PubMedCrossRefGoogle Scholar
  33. 33.
    Yanay O, Brogan TV, Martin LD (2004) Continuous pentobarbital infusion in children is associated with high rates of complications. J Crit Care 19(3):174–178PubMedCrossRefGoogle Scholar
  34. 34.
    Katz R, Kelly HW (1993) Pharmacokinetics of continuous infusion of fentanyl in critically ill children. Crit Care Med 21(7):995–1000PubMedCrossRefGoogle Scholar
  35. 35.
    Ginsberg B, Howell S, Glass PS et al (1996) Pharmacokinetic model-driven infusion of fentanyl in children. Anesthesiology 85(6):1268–1275PubMedCrossRefGoogle Scholar
  36. 36.
    Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11(5):354–365PubMedCrossRefGoogle Scholar
  37. 37.
    Bouwmeester NJ, Hop WC, van Dijk M et al (2003) Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism. Intensive Care Med 29(11):2009–2015PubMedCrossRefGoogle Scholar
  38. 38.
    Ivani G, Vercellino C, Tonetti F (2003) Ketamine: a new look to an old drug. Minerva Anestesiol 69:468–471PubMedGoogle Scholar
  39. 39.
    Jenkins I (2002) The provision of analgesia and sedation in the PICU: current practice and recent advances. Paed Anaesth 12(9):837–839CrossRefGoogle Scholar
  40. 40.
    Maze M, Tranquilli W (1991) Alfa-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 74:581–605PubMedCrossRefGoogle Scholar
  41. 41.
    Filos KS, Goudas LC, Patroni O et al (1992) Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Anesthesiology 77:267–274PubMedCrossRefGoogle Scholar
  42. 42.
    Eisenach JC, Rauck RL, Buzzanelli C et al (1989) Epidural clonidine analgesia for intractable cancer pain. Anesthesiology 71:647–652PubMedCrossRefGoogle Scholar
  43. 43.
    Ansermino M, Basu R, Vandebeek C et al (2003) Nonopioid additives to local anaesthetics for caudal blockade in children: a systematic review. Paediatr Anaesth 13(7):561–573PubMedCrossRefGoogle Scholar
  44. 44.
    Ambrose C, Sale S, Howells R et al (2000) Intravenous clonidine infusion in critically ill children: dose-dependent sedative effects and cardiovascular stability. Br J Anaesth 84(6):794–796PubMedGoogle Scholar
  45. 45.
    Arenas-Lopez S, Riphagen S, Tibby SM et al (2004) Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med 30(8):1625–1629PubMedCrossRefGoogle Scholar
  46. 46.
    Bhana N, Goa KL, McClellan KJ (2000) Dexmedetomidine. Drugs 59(2)263–270PubMedCrossRefGoogle Scholar
  47. 47.
    Venn RM, Grounds RM (2001) Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 87:684–690PubMedCrossRefGoogle Scholar
  48. 48.
    Tobias JD, Berkenbosch JW (2004) Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 97:451–455PubMedCrossRefGoogle Scholar
  49. 49.
    Martin LD, Bratton SL, O’Rourke P (1999) Clinical uses and controversies of neuromuscular blocking agents in infants and children. Crit Care Med 27:1358–1368PubMedCrossRefGoogle Scholar
  50. 50.
    Rhoney DH, Murry KR (2002) National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit. Pediatr Crit Care Med 3(2):129–133PubMedCrossRefGoogle Scholar
  51. 51.
    Tobias JD (2000) Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 28:2122–2132PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • M. L. Massone
    • 1
  • L. Manfredini
    • 1
  • G. Ottonello
    • 1
  1. 1.Department of Anaesthesia and Intensive CareG. Gaslini Institute Children’s HospitalGenoaItaly

Personalised recommendations